Barron's Streetwise
Kanaal Besonderhede
Barron's Streetwise
Get the lowdown on high finance each week with Barron’s columnist Jack Hough. Business leaders and trendspotters, insights and absurdities—this is Wall Street like you've never heard before.
Onlangse Episodes
306 episodes
Powell, Trump and Mortgage Rates
A top strategist from Barclays talks creative paths for pushing rates lower.
Learn more about your ad choices. Visit megaphone.fm/adchoi...
Small Cap Earnings Could Jump 20%. Plus, a Beer Mystery.
Jack talks with a top BofA Securities strategist and looks into a Wall Street theory on Corona sales and immigration policy.
Learn more a...
Pensions, Naked Puts, Low-Sin Investing
It’s a listener question special, and grill master Jack is ready to push the pace.
Learn more about your ad choices. Visit megaphone.fm/a...
Andrew Bary’s Top Stocks for 2026
The Barron’s star has a hot hand after crushing the market in 2025. Can he do it again?
Learn more about your ad choices. Visit megaphone...
Amazon’s Rufus Sales Tactics
In this half-fresh Black Friday episode, Jack talks about how Amazon is winning the shopping-bot war, and we revisit a June 27, 2025 episode on what’s...
BofA’s Favorite Non-AI Stocks. Plus, Nvidia’s Penny Dividend
A Wall Street researcher has 16 picks, and Jack pronounces 15 of them correctly. Also, what dinky dividends say about the market.
Learn m...
How Robinhood Went from Broken IPO to 1,000% Gainer
Chief brokerage officer Steve Quirk talks prediction markets and tokenization, and does a convincing dial-up modem impression.
Learn more...
Earnings Season Was Surprisingly Surprising
Jack discusses third-quarter company results, and answers listener questions on index funds and sequence-of-returns risk.
Learn more abou...
Is A.I. Spending Sustainable?
Barclays US equities strategist Venu Krishna talks about why this isn’t a replay of the dotcom bubble, and how nervous investors can hedge.
What Pfizer's New Deal Means for Healthcare
BMO Capital Markets analyst Evan Seigerman discusses the Trump Administration's deal with Big Pharma. Plus, meet the Suspicious 8, with 6% dividends a...
Bull Market Health Check. Plus, Philip Morris CEO Jacek Olczak
A top Wall Street strategist discusses A.I. and stock valuations. And Big Tobacco talks smokefree profits.
Learn more about your ad choic...
Nuclear Power’s Bright Outlook. Plus, Quarterly Or Semiannual Reporting?
A top Wall Street strategist talks fission (and fusion). And Jack has a guide to arguing about company reporting.
Learn more about your a...
Worldcoin's 3000% Gain. Plus, Gold, Dividends and Wedgification.
Crypto treasuries are dominating. Gold is up. Jack explains why, and answers listener questions on dividends.
Learn more about your ad ch...
Dividends for A Pricey Market
Is the stock market too expensive? Jack compares two perspectives. Plus, the deal on dividends.
Learn more about your ad choices. Visit...
Lyft’s Ride to Profit
Jack talks to Lyft CEO David Risher about the company's turnaround, autonomous driving, and whether they can beat rideshare's biggest company.
<...
Verizon and AT&T Have Traded Places
It could be Verizon’s turn for a stock bounce. Jack hears from the company’s CFO and a Wall Street bull.
Learn more about your ad choice...
How Low Will Mortgage Rates Go? Plus, e.l.f. Beauty
A Morgan Stanley strategist discusses the outlook for home loans and the appeal of mortgage backed securities. Jack chats with e.l.f. CEO Tarang Amin...
Can Government Data Be Trusted? Plus, Yeti and JNJ.
Jack talks to a strategist about the recent jobs revisions, and looks at two stocks that took very different paths after earnings.
Learn...
Climbing the Wealth Ladder
Jack sits down with personal finance expert Nick Maggiulli to talk strategies for building wealth at every level.
Learn more about your...
Disney's Lost Decade. What's Next?
Disney stock has slumped for the past 10 years, but most of Wall Street calls it a buy. Two bulls tell us why.
Learn more about your ad c...
Deep Dive on Garbage
Plus, why CVS prefers the second-best weight loss drug.
Learn more about your ad choices. Visit megaphone.fm/adchoices
Did the Optimists Triumph?
In this rerun, Jack explores 125-years of global investment returns. Plus: When hedging works and when it doesn't.
Learn more about your...
Roblox and Crocs. Plus, Van Eck On the Market
Jack talks fake farming and Jibbitz. And a top money manager explains how to invest now.
Learn more about your ad choices. Visit megapho...
Can Target Turn Things Around?
Jack talks with Barclays analyst Seth Sigman and Barron’s reporter Sabrina Escobar about the once-great growth stock.
Learn more about yo...
Retirement Catch-Up, IPO Heat Check, and the Market Effects of Index Funds
Jack answers listener questions with help from Barron's colleague Elizabeth O'Brien.
Learn more about your ad choices. Visit megaphone.f...
Government-Proofing Your Portfolio
Vanguard's Joseph Davis talks about megatrends, including the tug of war between AI and US government deficits. UBS's Mark Haefele discusses investing...
Coreweave's Tightrope Run
After a muted IPO, the A.I. stock is soaring. CoreWeave co-founder Brannin McBee breaks down the business. Barron's senior writer Adam Levine shares s...
The Kale of Investing Is Tasting Better
After decades of making sense only on paper, ex-US markets are suddenly shining.
Nanette Abuhoff Jacobson from Hartford Funds says it’s...
The Golden Age of Income
Bonds took a hit this week. BlackRock's Russ Brownback explains why that's an opportunity, and what investors should do now.
Learn more...
What’s Behind FICO’s Bodacious Stock Returns?
Jack looks at how the humble credit score has made investors more than 100,000%. Plus, Barron's reporter Mackenzie Tatananni answers a question about...
How to Invest for Tariff Purgatory
The market has bounced back from its 'Liberation Day' lows, but tariff shake-ups aren't over. What does that mean for you? Jack sits down with Bhanu B...
A Second Chance to Panic
Jack gives his thoughts on the market rebound, and previews Disney earnings. Plus, Allspring Portfolio Manager Bryant VanCronkhite gives us some stock...
New Weight Loss Pill. Plus, Congress and the Disappearing $4 Trillion.
In this vacation non-episode, Jack talks about Lilly’s latest trial breakthrough and the mysteries of federal budget reconciliation.
Lea...
Can You Dig It?
Jack gives gold bugs their due, and hears from strategists about what’s next for the metal, and mining stocks.
Learn more about your ad...
How Low Can We Go?
Jack examines the bear case on tariffs and hears from top strategists at Vanguard and real estate group Hines.
Learn more about your ad...
Southwest Airlines Turnaround Comes With Baggage
The low-cost carrier is adding fees and up-charges. Is it trying to mimic Spirit or Delta? And is the industry headed into a downturn?
Le...
Lululemon Is Stretched Thin
Randy Konik at Jefferies discusses yogawear woes and his Nike upgrade. Jack looks at how food insurgents are gobbling market share.
Learn...
Managed Futures, Infinite Banking, BDCs
Plus, Bitcoin ETFs. Time for a “great loop” through some listener questions.
Learn more about your ad choices. Visit megaphone.fm/adchoic...
10% Market Dip? How Not to React
Jack walks through ways to hedge market downside from foolish to sensible. Plus, we talk to Barry Ritholtz about strategies from his new book, How Not...
Is the S&P 500 Enough?
A 125-year history of financial returns challenges conventional wisdom. Plus:
When hedging works and when it fails with RBC's Amy Wu Sil...